Base Year
Historical Year
Forecast Year
The global stem cell assay market size was valued at USD 6.4 billion in 2023, driven by the rising funding to conduct stem cell research activities across the globe. The market is expected to grow at a CAGR of 13.18% during the forecast period of 2024-2032, with the values likely to rise from USD 7.2 billion in 2024 to USD 19.4 billion by 2032.
Stem cell assay is a laboratory technique utilized to assess the behaviour and properties of stem cells such as measuring their function. To study stem cell biology and investigate its potential therapeutic applications, stem cell assays are widely utilized across various sectors. The rising prevalence of chronic diseases such as cancer has increased the need for innovative therapies. With the global burden of new cancer cases predicted to reach approximately 30 million by 2040 , the stem cell assay market demand is expected to witness a surge in the coming years.
The market is experiencing a rising impetus for research and development activities in stem cell biology. Intensive research efforts are directed at utilizing stem cells in therapeutic applications, propelling the demand for stem cell assays. A study published in July 2023, revealed an innovative method to reverse cellular aging. The scientists involved in the study worked on expressing certain genes (Yamanaka factors) and converted adult cells into induced pluripotent stem cells (iPSCs). The researchers identified chemical cocktails that reverse cellular aging and restore youthful gene expression in less than a week without causing uncontrolled cell growth. Such developments led by robust research activities are estimated to fuel the stem cell assay market growth in the forecast period.
The market is also driven by the technological advancements in the sector resulting in improved efficiency and throughput of stem cell assays. Furthermore, the growing preference for personalized medicine and precision therapies will accelerate the market growth.
| Key Trends | Description |
| Expansion of Stem Cell Applications | Growing applications in regenerative medicine and drug discovery are driving the demand for stem cell assays. |
| Technological Innovations in Assay Platforms | Rising advancements in screening and 3D culture technologies are expected to enhance the efficiency of assays and aid improved outcomes. |
| Regulatory and Ethical Frameworks | Development and standardization of global regulatory and ethical frameworks are influencing the stem cell assay market dynamics. |
| Increased Investment in Research and Development Activities | Increasing investment in research and development activities to meet diverse clinical needs is positively influencing the market size |
Market Breakup by Product Type
The market is segmented by product type into kits and reagents, instruments, and services. Kits and reagents comprise consumables and chemical components required to conduct stem cell assays and facilitate cell culture. This segmentation reflects the diverse range of products and services in demand by the researchers and biopharmaceutical companies engaged in stem cell studies.
Market Breakup by Technology
The market breakup by technology in the global stem cell assay market includes flow cytometry, high-content screening, PCR (Polymerase Chain Reaction), spectrophotometry, microarray, and other technologies. These techniques are utilized in stem cell research and analysis and are expected to fuel the stem cell assay market size.
Market Breakup by Assay Type
By assay types, the market is divided into viability/cytotoxicity assays, isolation/purification assays, differentiation assays, proliferation assays, apoptosis assays, and other assay types. These assays are used to evaluate various aspects of stem cell biology.
Market Breakup by Cell Type
The market breakup by cell type includes adult stem cells, embryonic stem cells, and induced pluripotent stem cells (iPSCs). The market segment elucidates the diverse sources of stem cells needed in research and therapeutic applications.
Market Breakup by Application
Major applications of the global stem cell assay market share include drug discovery and development, regenerative medicine and therapy development, clinical research, and other applications.
Market Breakup by End User
End users of the market are pharmaceutical and biotechnology companies, research institutes, and contract research organizations (CROs), among others. Pharmaceutical and biotechnology companies hold a significant market share in the segment, utilizing stem cell assays in drug discovery, development, and testing.
Market Breakup by Region
The market breakup by region includes North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is a major market which can be attributed to the significant investments in research and development by various sectors, advanced healthcare infrastructure, and growing demand for personalized medicines.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Assay Type |
|
| Breakup by Cell Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 6.4 billion in 2023 driven by the rising funding in stem cell research across the globe.
The market is anticipated to grow at a CAGR of 13.18% during the forecast period of 2024-2032, likely to reach a market value of USD 19.4 billion by 2032.
Technological advancements in stem cell assay techniques such as the development of high-output screening platforms and 3D cell culture techniques are fuelling the demand for the market.
One of the significant trends in the market is the increased research and development activities in stem cell biology. In July 2023, a study published in the biomedical journal discovered a way to reverse cellular aging. The study was based on expressing certain genes (Yamanaka factors), and converting adult cells into induced pluripotent stem cells (iPSCs).
Based on the product type, the market is segmented into kits and reagents, instruments, and services.
Technologies available in the market include flow cytometry, high-content screening, PCR (polymerase chain reaction), spectrophotometry, microarray, and other technologies.
By assay types, the market is divided into viability/cytotoxicity assays, isolation/purification assays, differentiation assays, proliferation assays, apoptosis assays, and other assay types.
The market breakup by cell type includes adult stem cells, embryonic stem cells, and induced pluripotent stem cells (iPSCs).
End users of the market are pharmaceutical and biotechnology companies, research institutes, and contract research organizations (CROs), among others.
Major applications areas of stem cell assay include drug discovery and development, regenerative medicine and therapy development, clinical research, and other applications.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), PerkinElmer, Inc., GE Healthcare, Bio-Rad Laboratories, Inc., STEMCELL Technologies Inc., Cell Biolabs, Inc., Promega Corporation, Lonza Group, Miltenyi Biotec, Cell Signaling Technology, Inc., Agilent Technologies, Inc., R&D Systems (a Bio-Techne brand), Bio-Techne Corporation, and Cytiva (formerly GE Healthcare Life Sciences).
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share